Semisynthetic antibiotic obtained by reacting 3-formylrifamycin SV with 1-amino-4-methylpiperazine in tetrahydrofuran. Prepn and structure: Maggi et al., Chemotherapia 11, 285 (1966); NL 6509961; Maggi, Sensi, US 3342810 (1966, 1967 both to Lepetit). Chemical and biological properties: Fürész, Antibiot. Chemother. 16, 316 (1970). Activity studies and clinical survey: Arioli et al., Arzneim.-Forsch. 17, 523 (1967); Pallanza et al., ibid. 529; Bergamini, ibid. 20, 1546 (1970); Dans et al., Am. J. Med. Sci. 259, 120 (1970). Metabolism: Meyer-Brunot et al., Int. Congr. Chemother. Proc., 5th, Vienna 1967 1(2), 763; Fürész et al., Arzneim.-Forsch. 17, 534 (1967); Maggi et al., ibid. 19, 651 (1969). Inhibition of protein synthesis in mammalian cells: W. C. Buss et al., Science 200, 432 (1978). Comprehensive reviews: Binda et al., Arzneim.-Forsch. 21, 1907-1978 (1971); Lester, Annu. Rev. Microbiol. 26, 88-102 (1972). Comprehensive description: G. G. Gallo, P. Radaelli, Anal. Profiles Drug Subs. 5, 467-513 (1976). Symposium on the use of rifampin in the treatment of nontuberculous infections: Rev. Infect. Dis. 5, Suppl. 3, S399-S632 (1983).
Antibacterial (tuberculostatic).
Antibacterial (Antibiotics); Ansamycins; Antibacterial (Tuberculostatic)